Accuray Shares Outstanding 2006-2018 | ARAY

Current and historical number of shares outstanding for Accuray (ARAY) from 2006 to 2018. Diluted shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options.
Accuray Annual Shares Outstanding
(Millions of US $)
2017 $82
2016 $81
2015 $78
2014 $76
2013 $73
2012 $71
2011 $60
2010 $60
2009 $59
2008 $60
2007 $31
2006 $16
2005 $14
Accuray Quarterly Shares Outstanding
(Millions of US $)
Q3 2018 $85
Q2 2017 $85
Q1 2017 $84
Q4 2017 $82
Q3 2017 $83
Q2 2016 $82
Q1 2016 $82
Q4 2016 $81
Q3 2016 $82
Q2 2015 $80
Q1 2015 $80
Q4 2015 $78
Q3 2015 $79
Q2 2014 $78
Q1 2014 $77
Q4 2014 $76
Q3 2014 $76
Q2 2013 $75
Q1 2013 $75
Q4 2013 $73
Q3 2013 $74
Q2 2012 $73
Q1 2012 $72
Q4 2012 $71
Q3 2012 $71
Q2 2011 $71
Q1 2011 $70
Q4 2011 $60
Q3 2011 $60
Q2 2010 $61
Q1 2010 $59
Q4 2010 $60
Q3 2010 $60
Q2 2009 $57
Q1 2009 $57
Q4 2009 $59
Q3 2009 $59
Q2 2008 $58
Q1 2008 $55
Q4 2008 $60
Q3 2008 $60
Q2 2007 $61
Q1 2007 $61
Q4 2007 $31
Q3 2007 $37
Q2 2006 $16
Q1 2006 $50
Q3 2006 $16
Q2 2005 $16
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.330B $0.383B
ACCURAY INCORPORATED based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 40,000 patients worldwide and currently more than 130 systems have been installed in leading hospitals in the Americas, Europe and Asia.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $93.215B 22.36
Intuitive Surgical (ISRG) United States $59.265B 56.57
Fresenius Medical Care (FMS) Germany $29.358B 20.74
Edwards Lifesciences (EW) United States $28.908B 32.56
IDEXX Laboratories (IDXX) United States $21.087B 64.08
ABIOMED (ABMD) United States $16.956B 138.91
Hologic (HOLX) United States $11.065B 18.82
DexCom (DXCM) United States $10.899B 0.00
Teleflex (TFX) United States $10.447B 24.85
Varian Medical Systems (VAR) United States $10.178B 25.62
STERIS (STE) United Kingdom $9.709B 26.70
LivaNova (LIVN) United Kingdom $5.976B 35.65
Masimo (MASI) United States $5.677B 37.80
Integra LifeSciences Holdings (IART) United States $5.353B 27.70
Globus Medical (GMED) United States $5.144B 34.22
Inogen (INGN) United States $4.848B 128.30
Penumbra (PEN) United States $4.275B 388.59
Cantel Medical (CMD) United States $3.989B 41.58
Opko Health (OPK) United States $3.034B 0.00
Wright Medical Group (WMGI) Netherlands $2.990B 0.00
Halyard Health (AVNS) United States $2.966B 24.41
Integer Holdings (ITGR) United States $2.263B 20.49
Nevro (NVRO) United States $1.934B 0.00
Tandem Diabetes Care (TNDM) United States $1.644B 0.00
AxoGen (AXGN) United States $1.474B 0.00
Glaukos (GKOS) United States $1.464B 839.00
Mazor Robotics (MZOR) Israel $1.309B 0.00
Luminex (LMNX) United States $1.213B 35.79
CryoLife (CRY) United States $1.208B 105.97
Accelerate Diagnostics (AXDX) United States $1.204B 0.00
Natus Medical (BABY) United States $1.187B 25.18
Tactile Systems Technology (TCMD) United States $1.048B 178.59
K2Ms (KTWO) United States $0.909B 0.00
Intersect ENT (XENT) United States $0.838B 0.00
AngioDynamics (ANGO) United States $0.788B 29.25
Mesa Laboratories (MLAB) United States $0.782B 48.40
ViewRay (VRAY) United States $0.744B 0.00
Sientra (SIEN) United States $0.594B 0.00
Pacific Biosciences Of California (PACB) United States $0.581B 0.00
Neuronetics (STIM) United States $0.561B 0.00
Quotient (QTNT) Switzerland $0.417B 0.00
Veracyte (VCYT) United States $0.414B 0.00
GenMark Diagnostics (GNMK) United States $0.411B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.376B 0.00
OrthoPediatrics (KIDS) United States $0.353B 0.00
IRadimed (IRMD) United States $0.296B 106.54
RTI Surgical (RTIX) United States $0.285B 56.25
T2 Biosystems (TTOO) United States $0.283B 0.00
Fluidigm (FLDM) United States $0.281B 0.00
Nuvectra (NVTR) United States $0.259B 0.00
Pulse Biosciences (PLSE) United States $0.254B 0.00
Helius Medical Technologies (HSDT) United States $0.213B 0.00
SeaSpine Holdings (SPNE) United States $0.205B 0.00
Apollo Endosurgery (APEN) United States $0.170B 0.00
Ekso Bionics Holdings (EKSO) United States $0.160B 0.00
Alphatec Holdings (ATEC) United States $0.137B 0.00
Second Sight Medical Products (EYES) United States $0.108B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.102B 0.00
Sensus Healthcare (SRTS) United States $0.097B 0.00
EDAP TMS (EDAP) France $0.091B 0.00
Invuity (IVTY) United States $0.087B 0.00
Viveve Medical (VIVE) United States $0.082B 0.00
Neovasc (NVCN) Canada $0.067B 0.00
ConforMIS (CFMS) United States $0.061B 0.00
Restoration Robotics (HAIR) United States $0.043B 0.00
Vermillion (VRML) United States $0.041B 0.00
Presbia (LENS) Ireland $0.037B 0.00
Lianluo Smart (LLIT) China $0.033B 0.00
OBALON THERPTCS (OBLN) United States $0.031B 0.00
ReWalk Robotics (RWLK) Israel $0.029B 0.00
Titan Medical (TMDI) Canada $0.028B 0.00
Microbot Medical (MBOT) United States $0.027B 0.00
DarioHealth (DRIO) Israel $0.026B 0.00
PAVmed (PAVM) United States $0.025B 0.00
Dynatronics (DYNT) United States $0.023B 0.00
Nanovibronix (NAOV) United States $0.018B 0.00
Bioanalytical Systems (BASI) United States $0.013B 0.00
Allied Healthcare Products (AHPI) United States $0.009B 0.00
ENDRA Life Sciences (NDRA) United States $0.009B 0.00
Sunshine Heart Inc (CHFS) United States $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
Avinger (AVGR) United States $0.007B 0.00
Atossa Genetics (ATOS) United States $0.006B 0.00
Amedica (AMDA) United States $0.002B 0.00
EnteroMedics (RSLS) United States $0.001B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00